Abstract
Programmed cell death 1 (PD-1) and its ligand (PD-L1) are key physiologic suppressors of the cytotoxic immune reaction. However, to date, the combination of PD1/PD-L1 expression and tumor-infiltrating lymphocytes (TILs) and antigen-presenting cells has been only minimally reported in breast carcinoma, in particular in relation to HER2-positive cases. The goal of this study was to evaluate both cellular tumoral immune reaction and PD-L1/PD1 distribution in HER2-positive cases, as well as any associations with clinical outcome using conventional chemotherapy combined with HER2 blocking. Multicolor immunohistochemical multiplex assays simultaneously demonstrating PD1, PD-L1, and CD8 or PD-L1, CD3, and CD163 were performed on tissue microarrays (TMA) representing 216 pretreatment cases of HER2-positive invasive breast carcinoma. PD-L1 expression was identified in 38 cases (18%), including 12 cases (6%) with PD-L1 labeling of tumor cells and 26 cases (12%) with PD-L1 labeling of immune cells only. Ten of 12 cases with PD-L1 staining of tumor cells showed staining of associated immune cells as well. With this assay method, PD1 was detectable in many fewer cases (6 cases or 3%). PD-L1 expression was positively associated with high Not...Continue Reading
References
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A K TandonW L McGuire
Jan 9, 1987·Science·D J SlamonW L McGuire
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A CobleighD J Slamon
Mar 15, 2001·The New England Journal of Medicine·D J SlamonL Norton
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Apr 7, 2009·The Oncologist·Jeffrey S RossGabriel N Hortobagyi
Feb 10, 2011·Genes, Chromosomes & Cancer·Cecily P VaughnWade S Samowitz
Mar 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erin M Olson
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 31, 2012·Science Translational Medicine·Janis M TaubeLieping Chen
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Nov 13, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Vamsidhar VelchetiDavid L Rimm
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
Apr 26, 2014·Cancer Immunology Research·Elizabeth A MittendorfGheath Alatrash
Feb 12, 2015·Oncotarget·Renaud SabatierFrançois Bertucci
Mar 15, 2015·Science·Naiyer A RizviTimothy A Chan
Apr 22, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H R AliC Caldas
Aug 15, 2015·Cancer Discovery·Antoni Ribas
Nov 4, 2015·Human Pathology·Ashley Cimino-MathewsLeisha A Emens
Nov 7, 2015·Human Pathology·Mauricio Z BaptistaJosé Vassallo
Nov 21, 2015·Histopathology·Rhiannon K BeckersSandra A O'Toole
Oct 21, 2016·Nature Immunology·Richard BeatsonJoy M Burchell
Oct 11, 2016·Journal of breast cancer·Sang Byung BaeHyun Ju Lee
Jan 21, 2017·Oncotarget·Hitomi MoriMasafumi Nakamura
Feb 15, 2017·The American Journal of Surgical Pathology·Erik A DillAnne M Mills
Dec 5, 2017·Clinical Breast Cancer·Yanjun HouZaibo Li
Citations
Mar 30, 2019·International Journal of Cancer. Journal International Du Cancer·Jesse FestCasper H J van Eijck
Jun 18, 2020·Cancers·Essia MezniAnthony Gonçalves
Sep 14, 2019·Cancer Cell International·Cui JiangTao Sun
Sep 8, 2020·Thoracic Cancer·Hongling LiangYi-Long Wu
Jul 14, 2019·Histochemistry and Cell Biology·Albert Gibert-RamosMarylène Lejeune
Oct 31, 2019·Journal of Hematology & Oncology·E KrasniqiP Vici
Oct 28, 2019·Oncoimmunology·Deepak MittalMark J Smyth
Nov 5, 2019·Frontiers in Oncology·Ramy R SalehAlberto Ocaña
Mar 29, 2020·Systematic Reviews·Isnard Elman LitvinAdriana Vial Roehe
Mar 14, 2020·Cancers·Regina PadmanabhanAla-Eddin Al Moustafa
Mar 24, 2020·British Journal of Cancer·Yoonjin KwakHye Seung Lee
Jul 31, 2019·Breast Cancer Research and Treatment·Wenfa HuangHuiping Li
Apr 18, 2019·Cancers·Ya-Chin HouYan-Shen Shan
Jul 28, 2020·Breast Cancer Research and Treatment·Jing ZhaoXiaoxian Li
Oct 7, 2020·Drugs·Megan E Tesch, Karen A Gelmon
Dec 22, 2020·Frontiers in Oncology·Piotr TymoszukChrista Pfeifhofer-Obermair
Dec 29, 2020·Frontiers in Pharmacology·Victor Manuel Ruiz-RodríguezDiana Patricia Portales-Pérez
Dec 31, 2019·Seminars in Cancer Biology·Semir VranicJuan Palazzo
Jan 19, 2021·European Journal of Pharmacology·Patience SetordziDaiying Zuo
May 9, 2021·The British Journal of Surgery·M G DaveyM J Kerin
Jan 16, 2021·Breast Care·Eva Valentina Klocker, Christoph Suppan